Penote, Finn Alaister B.
HRN: 23-89-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/18/2024
12/25/2024
IVT
530mg IVt
Q6
PCAP-B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes